RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 59 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,298,085 | +16.1% | 2,534,220 | 0.0% | 47.73% | +158.8% |
| Q2 2023 | $16,624,483 | +15.4% | 2,534,220 | +5.2% | 18.44% | +10.6% |
| Q1 2023 | $14,407,136 | +156.7% | 2,409,220 | 0.0% | 16.67% | +154.6% |
| Q4 2022 | $5,613,482 | -30.4% | 2,409,220 | 0.0% | 6.55% | -30.1% |
| Q3 2022 | $8,071,000 | +26.4% | 2,409,220 | 0.0% | 9.37% | -0.1% |
| Q2 2022 | $6,384,000 | -9.9% | 2,409,220 | 0.0% | 9.38% | +29.0% |
| Q1 2022 | $7,083,000 | -65.6% | 2,409,220 | 0.0% | 7.27% | -50.5% |
| Q4 2021 | $20,599,000 | +14.8% | 2,409,220 | 0.0% | 14.70% | +387.8% |
| Q3 2021 | $17,949,000 | -20.1% | 2,409,220 | 0.0% | 3.01% | -31.4% |
| Q2 2021 | $22,478,000 | – | 2,409,220 | – | 4.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
| Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
| Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
| NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
| Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
| Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
| Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
| Ergoteles LLC | 37,640 | $126,000 | 0.00% |
| MAI Capital Management | 63,210 | $212,000 | 0.00% |
| RBF Capital, LLC | 14,536 | $49,000 | 0.00% |